We sought to identify additional biomarkers to improve diagnostics, and we assessed expression of IGF2BP3 in a population-based pediatric cohort of B-ALL using a tissue microarray platform. The gene discussed is IGF2BP3; the disease is acute lymphoblastic leukemia.